Mostrar el registro sencillo

dc.contributor.authorPaiva, Bruno
dc.contributor.authorChandia, Mauricio
dc.contributor.authorPuig, Noemi
dc.contributor.authorVidriales, Maria-Belen
dc.contributor.authorPerez, Jose J.
dc.contributor.authorLopez-Corra, Lucia
dc.contributor.authorOcio San Miguel, Enrique María 
dc.contributor.authorGarcia-Sanz, Ramon
dc.contributor.authorGutierrez, Norma C
dc.contributor.authorJimenez-Ubieto, Ana
dc.contributor.authorLahuerta, Juan-José
dc.contributor.authorMateos, Maria-Victoria
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2024-03-14T08:27:19Z
dc.date.available2024-03-14T08:27:19Z
dc.date.issued2015
dc.identifier.issn0390-6078
dc.identifier.issn1592-8721
dc.identifier.urihttps://hdl.handle.net/10902/32239
dc.description.sponsorshipThis study was supported by the Cooperative Research Thematic Network grants RD12/0036/0058 of the Red de Cancer (Cancer Network of Excellence); Instituto de Salud Carlos III, Spain, Instituto de Salud Carlos III/Subdirección General de Investigación Sanitaria (FIS: PI060339; 06/1354; 02/0905; 01/0089/01-02; PS09/01897/01370; G03/136; Sara Borrell: CD13/00340); and Asociación Española Contra el Cáncer (GCB120981SAN), Spain. The study was also supported internationally by the International Myeloma Foundation Junior Grant Proposal and the Multiple Myeloma Research Foundation research fellow award.es_ES
dc.format.extent3 p.es_ES
dc.language.isoenges_ES
dc.publisherFerrata Storti Foundationes_ES
dc.rightsAttribution-NonCommercial 4.0 International © Ferrata Storti Foundation. Paiva, B. et al., 2015, The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma "Obtained from the Haematologica Journal website http://www.haematologica.org"es_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.sourceHaematologica, 100(2), e53-55es_ES
dc.subject.otherMRDes_ES
dc.subject.otherRelapsees_ES
dc.subject.otherMyelomaes_ES
dc.subject.otherFlow cytometryes_ES
dc.titleThe prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myelomaes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.3324/haematol.2014.115162es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.3324/haematol.2014.115162
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution-NonCommercial 4.0 International  © Ferrata Storti Foundation. Paiva, B. et al., 2015, The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma "Obtained from the Haematologica Journal website http://www.haematologica.org"Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial 4.0 International © Ferrata Storti Foundation. Paiva, B. et al., 2015, The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma "Obtained from the Haematologica Journal website http://www.haematologica.org"